Biotechnology:-In-Vitro-&-In-Vivo-Diagnostic-Substances (20)
| Company | Ticker | 2026 | 2025 | |
|---|---|---|---|---|
| Lucira Health Inc. | LHDX | 0% | 0% | |
| ALX Oncology Holdings Inc. | ALXO | 0% | 8% | |
| Berkeley Lights Inc. | BLI | 0% | 0% | |
| VolitionRX Limited | VNRX | 0% | 10% | |
| OncoCyte Corporation | OCX | 0% | 0% | |
| Navidea Biopharmaceuticals Inc | NAVB | 0% | 0% | |
| Trinity Biotech plc | TRIB | 0% | 0% | |
| Quotient Limited | QTNT | 0% | 0% | |
| Quidel Corporation | QDEL | 0% | 0% | |
| Nymox Pharmaceutical Corporation | NYMX | 0% | 0% | |
| Neogen Corporation | NEOG | 0% | 1% | |
| Myriad Genetics Inc | MYGN | 0% | -0% | |
| Meridian Bioscience Inc | VIVO | 0% | 0% | |
| ImmuCell Corporation | ICCC | 0% | 0% | |
| IDEXX Laboratories Inc | IDXX | 0% | 1% | |
| Celldex Therapeutics Inc | CLDX | 0% | 6% | |
| ARCA biopharma Inc | ABIO | 0% | 0% | |
| Achieve Life Sciences Inc | ACHV | 0% | 4% | |
| Intellia Therapeutics Inc. | NTLA | 0% | 4% | |
| Lantheus Holdings Inc. | LNTH | 0% | 2% | |